Blood genomic expression signatures and key pathways determining valproate efficacy in patients with epilepsy

dc.contributor.guide	Ritushree Kukreti
dc.coverage.spatial
dc.creator.researcher	Chitra Rawat
dc.date.accessioned	2022-06-17T09:24:04Z
dc.date.available	2022-06-17T09:24:04Z
dc.date.awarded	2019
dc.date.completed	2019
dc.date.registered	2013
dc.description.abstract	newline
dc.description.note
dc.format.accompanyingmaterial	None
dc.format.dimensions
dc.format.extent	All Pages
dc.identifier.uri	http://hdl.handle.net/10603/387004
dc.language	English
dc.publisher.institution	Biological Sciences (CSIR-IGIB)
dc.publisher.place	Ghaziabad
dc.publisher.university	Academy of Scientific and Innovative Research (AcSIR)
dc.relation
dc.rights	university
dc.source.university	University
dc.subject.keyword	Biology
dc.subject.keyword	Biology and Biochemistry
dc.subject.keyword	Life Sciences
dc.title	Blood genomic expression signatures and key pathways determining valproate efficacy in patients with epilepsy
dc.title.alternative
dc.type.degree	Ph.D.